Looking to expand your partner network with leading companies like Wellcome Trust? Consider joining Inpart's global network for free.
News and Trends 3 Jan 2020
Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second grant installment funding development of a novel antibiotic for use against Pseudomonas infections in patients with cystic fibrosis. This is the second installment of a grant worth up to €7.6M awarded to Antabio in 2017. The French biotech was awarded […]